New Venture Support

Manager New Ventures

Dr Lewis Schulz

Email: lewis.schulz@unimelb.edu.au

Phone: 03 8344 3194

Lewis is team leader of the New Ventures group which plays a key role supporting technology transfer at Melbourne Ventures particularly through start-up company establishment and incubation. He has recently been instrumental in the successful capital raising for Otifex Therapeutics and continues to lead the phase II clinical development program for Hatchtech's novel pediculicide.

He has more than fifteen years first hand local and international experience with drug and device development and proven experience in CMC, nonclinical, regulatory and clinical development. Previous roles have involved various therapeutic areas including oncology, inflammation and dermatology and include six years in European posts with international pharmaceutical companies.

While working for Bristol Myers Squibb International, Lewis was instrumental in development and implementation of regulatory and marketing strategy for their oncology portfolio in the Central and Eastern European region.

He holds a Bachelor of Science (with Honours) and PhD in Chemistry from Monash University, Australia, and has completed a Diploma in Management from Henley College, UK.

Project Manager

Grant Morley

Email: grant.morley@unimelb.edu.au

Phone: 03 8344 3189

Grant is CEO of Velacor Therapeutics which originated from research at Melbourne University. In addition Grant manages technology transfer projects for the University.

Grant has more than 13 years regulatory and project management experience in the development of biotechnology and pharmaceutical products, with particular expertise in the preclinical and clinical development and registration of new products. He has successfully managed the development from laboratory to market of a range of pharmaceutical and medical products for CSL Limited and Norwood Abbey.

Grant has a Bachelor of Science and Master of Science degree from Monash University , and a Master of Medical Science (drug development) from UNSW.

Project Manager

Dr Grant McLachlan

Email: grant.mclachlan@unimelb.edu.au

Phone: 03 8344 3092

Melbourne Ventures’ newest Project Manager, Grant McLachlan joined the company in 2007.

Grant has spent the last 10 years in a variety of roles in drug and business development at IDT Australia, a contract service provider, specializing in active pharmaceutical ingredient process development and scale-up, formulation development, analytical method development and validation, and phase I clinical trials.  He has a degree in chemistry from the Monash University and a PhD in coordination chemistry from Monash University.  He completed a two-year post doctoral position in the USA, studying the interaction of metal complexes with DNA.

Grant has more than 10 years of project management experience in the development of biotechnology and pharmaceutical products, with particular expertise in the preclinical and clinical development of new drug substances and drug products.  He has successfully managed the development from laboratory to clinical trials of a range of pharmaceutical and medical products.

“Having spent most of my career to date working for a contract service provider, I am looking forward to being on the other side of the fence.  I have managed the drug development programs for companies ranging from virtual start-ups at the lead selection stage, to NDA filings for “Big Pharma”.  I believe that this has given me a relatively broad range of experiences at all stages of drug development, as well as different business methods and strategies for pharma companies.”

Grant is COO of Fibrotech which originated from research at Melbourne University. In addition Grant manages other technology transfer projects for the University.